GeneDx Holdings Corp., a genomics company, provides genetic testing services. It primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and information services. The company is headquartered in Stamford, Connecticut.

GeneDx Holdings Corp.

In a report released today, Mark Massaro from BTIG maintained a Buy rating on GeneDx Holdings, with a price target of $200.00. According to TipRank...

BTIG Keeps Their Buy Rating on GeneDx Holdings (WGS)

Cathie Wood cut two key “Magnificent 7” stocks on Thursday as part of a broad shift across her ARK ETFs. Fresh trade filings for December 4 show ne...

Why Cathie Wood Dumps Two ‘Magnificent 7’ Stocks — and Makes a Bold Bet on Trade Desk (TTD) Instead

In a report released today, David Westenberg from Piper Sandler maintained a Buy rating on GeneDx Holdings, with a price target of $160.00. Accordi...

Piper Sandler Remains a Buy on GeneDx Holdings (WGS)

Cathie Wood’s ARK Invest ETFs (exchange-traded funds) released their daily trades for Wednesday, December 3, 2025, showing a mix of new buys and st...

Market Cap	$4.15B	P/E Ratio	248.38
52W High	$170.87	52W Low	$55.17
Div Yield	N/A	Payout Ratio	0.0%
EPS Growth 3Y	70.4%	52W Position	83.3%
Overall Score	48	Value Score	20
Quality Score	60	Technical Score	66

EPS Current Est	$0.61	EPS Next Est	$0.58
EPS Growth Est	-4.9%	DPS Growth 3Y	N/A

	A	B	C	D
1	Symbol	Price	Change	Volume
2	WGS	$151.51	-2.48%	510.41K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	WGS	$151.51	-2.5%	510.41K
3
4
5
6

WGS

WGS

Key Metrics Overview

Growth Analysis

Revenue (5Y)

EBITDA (5Y)

Get GeneDx Holdings Corp. Data in Excel

Get GeneDx Holdings Corp. Data in Excel